Sivik Global Healthcare LLC Invests $2.19 Million in Stevanato Group S.p.A. $STVN

Sivik Global Healthcare LLC acquired a new stake in Stevanato Group S.p.A. (NYSE:STVN) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 85,000 shares of the company’s stock, valued at approximately $2,189,000.

A number of other institutional investors also recently added to or reduced their stakes in the business. Cooper Investors PTY Ltd. raised its stake in shares of Stevanato Group by 251.7% during the 3rd quarter. Cooper Investors PTY Ltd. now owns 590,308 shares of the company’s stock worth $15,200,000 after buying an additional 422,478 shares in the last quarter. Bar Harbor Wealth Management raised its position in Stevanato Group by 1.8% in the third quarter. Bar Harbor Wealth Management now owns 378,491 shares of the company’s stock worth $9,746,000 after acquiring an additional 6,756 shares in the last quarter. Farther Finance Advisors LLC acquired a new stake in Stevanato Group in the third quarter valued at $44,000. Orion Porfolio Solutions LLC lifted its holdings in Stevanato Group by 2.8% in the second quarter. Orion Porfolio Solutions LLC now owns 100,066 shares of the company’s stock valued at $2,445,000 after acquiring an additional 2,718 shares during the period. Finally, Ranger Investment Management L.P. boosted its position in shares of Stevanato Group by 125.6% during the 2nd quarter. Ranger Investment Management L.P. now owns 1,321,030 shares of the company’s stock worth $32,273,000 after purchasing an additional 735,417 shares in the last quarter.

Analysts Set New Price Targets

Several analysts recently commented on STVN shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Stevanato Group in a research note on Monday, December 29th. Morgan Stanley started coverage on shares of Stevanato Group in a research report on Monday, December 1st. They set an “equal weight” rating and a $24.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Stevanato Group Stock Performance

Shares of STVN opened at €21.63 on Wednesday. Stevanato Group S.p.A. has a 12-month low of €17.81 and a 12-month high of €28.00. The stock has a market cap of $6.55 billion, a P/E ratio of 37.95, a PEG ratio of 1.73 and a beta of 0.58. The company has a current ratio of 1.89, a quick ratio of 1.30 and a debt-to-equity ratio of 0.26. The company has a 50-day moving average of €22.22 and a two-hundred day moving average of €23.89.

Stevanato Group Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.